Substituted imidazotriazines

Details Substituted imidazotriazines Substituted imidazotriazines

2007-04-10

2007-04-10

Balasubramanian, Venkataraman (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S184000

Reexamination Certificate

active

10520552

ABSTRACT:
The invention relates to new substituted imidazotriazines, processes for their preparation and their use for the production of medicaments for the treatment and/or prophylaxis of cancer and neurodegenerative disorders, in particular of Parkinson's disease and of schizophrenia.

REFERENCES:
patent: 3941785 (1976-03-01), Clarke et al.
patent: 1092719 (2001-04-01), None
patent: 9924433 (1999-05-01), None
patent: 03000269 (2003-03-01), None
patent: 03000693 (2003-03-01), None
Siuciak et la., Neuropharmacology 1-11, 2006.
Rodefer et al., Eur. J. Neurosci. 21(4): 1070-1076, 2005.
Memory Pharmaceuticals Press Release Feb. 23, 2005, pp. 1-3.
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition, vol. 1, 1004-1010, 1996.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Vippagunta et al., Advanced Drug Delivery Reviews 48: 3-26, 2001.
Molina, et al., “Fused Imidazoles: A Novel Synthesis of Imidazo[1,2-b][1,2,4]triazole and Imidazo[5,1-f]-[1,2,4]triazine Derivatives,”Synthesis, Georg Thieme Verlag, Stuggart, 11, 843-847 (1989).

Affiliated with

Also associated with

Rating

Substituted imidazotriazines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted imidazotriazines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazotriazines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3780783